Facial Injectors Market Research Report - Global Forecast till 2030

Facial Injectors Market Information By Type (Dermal Fillers/Injectable Implants, Hyaluronic Acid, Synthetic Fillers, Collagen Fillers, Anti-Aging/Anti-Wrinkle Injections, Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Microparticles), By Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments), By End-User (Dermatology Clinics & Cosmetic Centers, Hospitals), By Region (Americas, Europe, Asia Pacific and The Middle East & Africa) – till 2030

ID: MRFR/HC/5433-CR | December 2018 | Region: Global | 122 Pages         

Facial Injectors Market

The Facial Injectors Market in the global market is expected to grow at a high CAGR of 11.40% and to reach the market value of USD 14571.47 million by the end of the forecasted period 2022-2030

Segmentation

By Type Dermal Fillers/Injectable Implants Hyaluronic Acid Synthetic Fillers Collagen Fillers Anti-Aging/Anti-Wrinkle Injections Botulinum Toxin A Poly-L-Lactic Acid (PLLA) Microparticles
By Application Lip Treatments Face-Lift Facial Line Correction Treatment Others
By End-User Hospitals Specialty Clinics Spa and Beauty Clinics Dermatology Clinics Cosmetic Centers

Key Players

  • SciVision Biotech Inc.
  • Ipsen Pharma
  • Merck KGaA
  • Sanofi Revance Therapeutics Inc.
  • Sinclair Pharma
  • Galderma S.A.
  • Medytox Inc.
  • Suneva Medical Inc.
  • Merz Pharma
  • Valeant Pharmaceuticals
  • Others

Drivers

  • Increasing craze for self-maintenance and beauty treatments
  • Awareness regarding aesthetic medicine to boost growth of Facial Injectors Market
Speak to Analyst Request a Free Sample

Facial Injectors Market Overview


The facial injectors market in the global market is expected to grow at a high CAGR of 11.40% during the forecasted period from 2022-2030 and to reach the market value of USD 14571.47 million by the end of the forecasted period 2022-2030.


The other name for facial injectors is the dermal fillers commonly used for facial rejuvenation with the help of products made from bio-engineering. With the increase in age, the collagen level in the skin starts decreasing which leads to loss of skin elasticity and loss of subcutaneous fat through which smile lines and wrinkle lines start to appear on the face as the skin is pulled towards facial working muscles. All these issues can easily be solved by using facial injectors market by using dermal fillers or facial injectors as it helps in treating the sign of aging and for adding extra glow.


COVID 19 Analysis


The global pandemic of COVID 19 has affected the facial injectors market in the global market. It has affected the health front and financial front in all the businesses that had pushed the economies into forced recession. Due to the outbreak of COVID 19 many hospitals, clinics, and other medical facilities were quite occupied in treating the patients of COVID 19 and hence leads to the downfall of revenues of the market in the global market. Also during the lockdown situation, the facial injector market has faced a steep downfall in their profits during the forecasted period.


The facial injectors market in the global market is expected to recover from this situation of the global pandemic at the end of the first quarter and beginning of the second quarter in the coming year during the forecasted period.


Market Dynamics


Drivers


Owing to the increasing craze for self-maintenance and beauty treatments has driven the market in the global market to great extent. The rise in the adoption of soft tissue fillers in aesthetic medicine helps in boosting the growth of the market in the global market during the forecasted period. The increasing awareness regarding aesthetic medicine also boosts the growth of the facial injectors market.


Opportunities


The increasing demand for facial injectors market. Most of the population in the American region, Asia-Pacific region, Europe region is of mid-age or elderly population. For retaining the elasticity of the skin many people use these facial injectors and hence gives growth opportunities for the market in the global market. Also, the rising awareness and acceptance of aesthetics treatment increase the market opportunities for the market.


Restraints


The Facial injector market is increasing at a fast pace in the global market but some factors restrain the growth of the facial injectors market like the associated side-effects from the facial injectors and aesthetic treatment and medicines. The other factor that hampers the growth of the market is the global market is the high cost of treatment along with high maintenance costs after the surgery or treatment. Stringent procedure regulations also hinder market growth.


Value Chain Analysis


The facial injectors market in the global market is rising at a fast pace all across the world and provides various benefits owing to its various advantages. Owing to the increase in the entertainment sector there is a huge market for market and provides surgeries and treatment for making the skin of the actors and actresses youthful. Now not even females are looking forward to aesthetic treatment but the participation of males is also increasing day by day. It is forecasted that the market will rise during the estimated period.


Market Segmentation


The facial injectors market in the global market has been divided based on type, application, end-user, and region.


Based on the Type


The market in the global market has been divided based on type into two broad categories like dermal fillers/injectable implants and anti-aging/anti-wrinkle injections. The dermal filler/injectable implants are further divided into collagen fillers, synthetic fillers, and hyaluronic acid. The anti-aging/anti-wrinkle injections are further divided into botulinum toxin A and Poly-L-Lactic Acid (PLLA) Microparticles.


Based on the Application


The market in the global market has been divided based on application into lip treatments, face-lift, and facial line correction treatment, and many others.


Based on the End-User


The market in the global market has been divided based on end-users into hospitals, specialty clinics, Spa and beauty clinics, dermatology clinics, and cosmetic centers.


Based on the Region


The facial injectors market in the global market has been divided based on region into the Americas region, the Europe region, the Asia-Pacific region, the Middle East and Africa region, and the rest of the world.


Regional Analysis


The facial injectors market in the global market has been divided based on region into the Americas region, the Europe region, the Asia-Pacific region, the Middle East, and Africa region. The largest-share in the facial injectors market in the global market has been held by the Americas region owing to the increasing use of expenditure on cosmetic products and various procedures in many countries like the U.S. and Canada because of its huge population during the forecasted period. Also, the increasing craze of enhancing the physical appearance drives the beauty treatments and hence drives the market in the Americas region.


Owing to the fastest-growing region the Asia-Pacific region also shows a positive growth rate for the market. The increasing population of mid-age people and elderly population and their growing concern about beauty in the region and hence drives the market in the Asia-Pacific region during the forecasted period from 2016 to 2023.


Competitive Landscape


The most prominent market players in the global market are the following:



  • SciVision Biotech Inc.

  • Ipsen Pharma

  • Merck KGaA

  • Sanofi Revance Therapeutics Inc.

  • Sinclair Pharma

  • Galderma S.A.

  • Medytox Inc.

  • Suneva Medical Inc.

  • Merz Pharma

  • Valeant Pharmaceuticals

  • Allergan and Integrated

  • Life Sciences Corporation


These market players in the facial injectors market in the global market uses various market strategies to capture the potential customer base all across the globe by creating innovative products, mergers and acquisitions, and different partnerships.


Recent Developments



  • In April 2019, the launch of Belotero Revive has been launched by Merz Pharma that is a combination of glycerol and HA that helps in treating fine lines by improvement in elasticity, skin firmness, and hydration. It helps in expanding the product line of the medical aesthetics business segment.

  • In September 2019, the approval from U.S. FDA for Juvederm VOLUMA XC has been announced by Allergan plc with TSK STEEiGLIDE cannula for the lifting of cheeks. It helps in correcting age-related in mid-face. This approval will help in expanding the Juvederm family of fillers demand in the global market.

  • In February 2018, Elastagen has been acquired by Allergan for incorporating Elastagen’s clinical-stage Tropoelastin platform for enhancing the facial injection portfolio in the global market.

  • In the market, the largest share in the market in the dermal fillers in aesthetic surgeries is hyaluronic acid for increasing facial procedures in boosting the market in the global market.

  • Advancement in technology and its application in the cosmetic industry helps in increasing the market share of the market for boosting the growth of the cosmetic market in the global market.


Report Overview


The facial injectors market research report consists of the following aspects:



  • Market Overview

  • COVID 19 Analysis

  • Market Dynamics

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments



The market research report consists of various factors that drive and restrains the market in the market in the global market. This report also provides opportunities and the impact of COVID 19 on the global market of market. The future growth rate is also estimated and mentioned.


Users


Investors and trade experts, Governments, associations, and industrial bodies, retailers, distributors, and wholesalers, personal care industry, venture capitalists, life science research institutes, contract research organizations, and pharmaceutical and biopharmaceutical companies, and many others.



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 14571.47 million
  CAGR   11.40%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD million)
  Report Coverage    Revenue Forecast, Competitive Landscape, Growth Factors, and Regional Analysis
  Segments Covered   By Type, By Application, By End-User, By Region
  Geographies Covered   Americas, Europe, Asia Pacific and The Middle East & Africa
  Key Vendors   SciVision Biotech Inc., Ipsen Pharma, Merck KGaA, Sanofi Revance Therapeutics Inc., Sinclair Pharma, Galderma S.A., Medytox Inc., Suneva Medical Inc., Merz Pharma, Valeant Pharmaceuticals, Allergan and Integrated, Life Sciences Corporation
  Key Market Opportunities   The increasing demand for facial injectors market. Most of the population in the American region, Asia-Pacific region, Europe region is of mid-age or elderly population. Also, the rising awareness and acceptance of aesthetics treatment increase the market opportunities for the market.
  Key Market Drivers

  • Increasing craze for self-maintenance and beauty treatments
  • Awareness regarding aesthetic medicine to boost growth of Facial Injectors Market


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Facial Injectors Market would grow up to a valuation of USD 14571.47 million by 2030.

    Facial Injectors Market would register a CAGR of 11.40% during the forecast period of 2022-2030.

    Dermatology clinics & cosmetic centers segment would lead the Facial Injectors Market.

    Facial line correction segment has the upper hand in the Facial Injectors Market.

    Americas market would lead the Facial Injectors Market ahead

    Numerous players are operating in the global facial injectors market. Some of the big players have captured a significant share in the global market, taking advantage of their strong position and presence in the number of countries and regions across the world.


    The top players in the global facial injectors market are Allergan, Ipsen Pharma, Merz Pharma, Galderma S.A., and Sinclair Pharma. Allergan accounted for 25.5% of the global facial injectors market share in 2017. It is one of the largest and fastest growing market players in the aesthetics and cosmetic procedures segment.


    Ipsen Pharma accounted for the second-largest market share of 20.0% in 2017. It operates in endocrinology, oncology, neurology, cognitive disorders, gastroenterology, and rheumatology areas. The company has a strong research and development unit which offers innovative products.


    Merz Pharma operates in segments, namely, neurology, over the counter (OTC) medicine, dietary supplements, and skincare products. The company accounted for 18.5% of the total market share in 2017.


    Galderma S.A. holds the fourth largest position in the global facial injectors market with a market share of 17.0%. It is one of the largest dermatology medicine manufacturers in the world and it has strategic partnerships with many strong brands.


    Sinclair Pharma is into manufacturing and marketing of pharmaceuticals, aesthetics, and cosmetic products. The company has a strong presence in the major aesthetics market. It holds the fifth largest position in the global facial injectors market with a market share of 5.8%.


    Intended Audience



    • Dermal fillers manufacturers & suppliers

    • Research and development (R&D) companies

    • Market research and consulting service providers

    • Academic institutes and universities